http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022122233-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9132936ffb062c812dc300c713b70762 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
| filingDate | 2021-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f70b3df785b195ae05e3be561b3c20b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c341d642e18548ed0ef35ed44f9db2c |
| publicationDate | 2022-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022122233-A |
| titleOfInvention | cell treatment agent |
| abstract | [Problem] To suppress the death of cells in a tissue or cultured cells, and to maintain their viability, for example, exfoliation/floatation treatment, dormancy treatment (dormancy has a protective effect) not only increase cell growth, but also suppress unnecessary differentiation of cells to maintain an undifferentiated/low-differentiated state), protective treatment for preservation and transportation, etc., and a dormant state. To provide a method capable of safely and simply performing a cell activation treatment for inoculating suspended cells. Kind Code: A1 A cell treating agent containing, as an active ingredient, at least one selected from alginic acid, heparins, sulfated dextrans and protease inhibitors. [Selection figure] None |
| priorityDate | 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.